Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies
- PMID: 2452893
- PMCID: PMC253268
- DOI: 10.1128/JVI.62.6.1870-1874.1988
Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies
Abstract
The neutralization epitopes of human and simian rotavirus protein VP7 were studied by producing six neutralizing monoclonal antibodies (N-MAbs) and using these N-MAbs to select antigenic mutants that resisted neutralization by the N-MAbs used for their selection. Cross-neutralization tests between the N-MAbs and the antibody-selected antigenic mutants identified one cross-reactive and five distinct serotype-specific neutralization epitopes which operationally overlapped one another and constituted a single antigenic site. In addition, the amino acid substitutions in human rotavirus VP7 that are responsible for the antigenic alterations in the mutants selected with anti-VP7 cross-reactive or serotype-specific N-MAbs were identified. All the amino acid substitutions in the antigenic mutants occurred in one of two variable regions: amino acids 87 to 101 and 208 to 221.
Similar articles
-
Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.J Gen Virol. 1988 Feb;69 ( Pt 2):451-8. doi: 10.1099/0022-1317-69-2-451. J Gen Virol. 1988. PMID: 2448418
-
Analysis of the newly identified neutralization epitopes on VP7 of human rotavirus serotype 1.J Gen Virol. 1991 Jan;72 ( Pt 1):117-24. doi: 10.1099/0022-1317-72-1-117. J Gen Virol. 1991. PMID: 1703558
-
Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.Arch Virol. 1991;117(1-2):73-84. doi: 10.1007/BF01310493. Arch Virol. 1991. PMID: 1706592
-
VP4 and VP7 typing using monoclonal antibodies.Arch Virol Suppl. 1996;12:113-8. doi: 10.1007/978-3-7091-6553-9_13. Arch Virol Suppl. 1996. PMID: 9015108 Review.
-
Molecular determinant of rotavirus neutralization and protection.Adv Virus Res. 1989;36:181-214. doi: 10.1016/s0065-3527(08)60585-0. Adv Virus Res. 1989. PMID: 2472045 Review. No abstract available.
Cited by
-
Characterization by enzyme-linked immunosorbent assay using subgroup- and serotype-specific monoclonal antibodies of human rotavirus obtained from diarrheic patients in Bangladesh.J Clin Microbiol. 1989 Jul;27(7):1678-81. doi: 10.1128/jcm.27.7.1678-1681.1989. J Clin Microbiol. 1989. PMID: 2549093 Free PMC article.
-
Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.J Clin Microbiol. 1992 Jun;30(6):1392-7. doi: 10.1128/jcm.30.6.1392-1397.1992. J Clin Microbiol. 1992. PMID: 1320626 Free PMC article.
-
VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection.J Virol. 1991 Jun;65(6):3052-9. doi: 10.1128/JVI.65.6.3052-3059.1991. J Virol. 1991. PMID: 1709695 Free PMC article.
-
Evidence for two serotype G3 subtypes among equine rotaviruses.J Clin Microbiol. 1992 Feb;30(2):485-91. doi: 10.1128/jcm.30.2.485-491.1992. J Clin Microbiol. 1992. PMID: 1371520 Free PMC article.
-
The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus.J Virol. 1991 Mar;65(3):1383-91. doi: 10.1128/JVI.65.3.1383-1391.1991. J Virol. 1991. PMID: 1847459 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases